Skip to main content
Clinical Trials/NCT00899665
NCT00899665
Completed
N/A

Proteases in Prostate Cancer Bone Metastasis

Barbara Ann Karmanos Cancer Institute1 site in 1 country31 target enrollmentJuly 2001

Overview

Phase
N/A
Intervention
Not specified
Conditions
Anemia
Sponsor
Barbara Ann Karmanos Cancer Institute
Enrollment
31
Locations
1
Primary Endpoint
Expression and activity of proteases and related molecules
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

RATIONALE: Collecting and storing samples of bone marrow and tissue from patients to test in the laboratory may help the study of cancer.

PURPOSE: This laboratory study is comparing proteases (enzymes that break down protein) in patients with prostate cancer that has spread to the bone with patients who do not have cancer that has spread to the bone.

Detailed Description

OBJECTIVES: * Examine the roles of proteases and protease-associated molecules in bone metastases in patients with metastatic prostate cancer. OUTLINE: Patients undergo bone marrow aspiration and core bone biopsies. Tissues are analyzed by immunohistochemistry methods, in situ hybridization assays, gelatin zymography and/or Western blot analysis, and gene profiling analysis in order to visualize and quantitate protease or protease-related levels. PROJECTED ACCRUAL: A total of 50 patients will be accrued for this study.

Registry
clinicaltrials.gov
Start Date
July 2001
End Date
January 2008
Last Updated
12 years ago
Study Type
Observational
Sex
Male

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Expression and activity of proteases and related molecules

Study Sites (1)

Loading locations...

Similar Trials